We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+0.42%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$6.12B
AUM Growth
+$762M
Cap. Flow
+$908M
Cap. Flow %
14.82%
Top 10 Hldgs %
15.76%
Holding
794
New
208
Increased
110
Reduced
107
Closed
121

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$85M
2
ABT icon
Abbott
ABT
+$72M
3
NVDA icon
NVIDIA
NVDA
+$60.9M
4
TER icon
Teradyne
TER
+$52.2M
5
LEGN icon
Legend Biotech
LEGN
+$50.2M

Top Sells

Rank Stock Value
1
APH icon
Amphenol
APH
+$98.7M
2
TXN icon
Texas Instruments
TXN
+$95.4M
3
GPN icon
Global Payments
GPN
+$54.3M
4
JNJ icon
Johnson & Johnson
JNJ
+$49.4M
5
KLAC icon
KLA
KLAC
+$49M

Sector Composition

Rank Sector Weight
1 Healthcare 46.26%
2 Technology 25.67%
3 Communication Services 8.98%
4 Financials 5.47%
5 Consumer Staples 3.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PBH icon
301
Prestige Consumer Healthcare
PBH
$2.51B
$3.73M 0.06%
+66,488
New +$3.65M
IDYA icon
302
IDEAYA Biosciences
IDYA
$3.47B
$3.68M 0.06%
144,379
-92,316
-39% -$2.16M
HSKA
303
DELISTED
Heska Corp
HSKA
$3.64M 0.06%
14,065
-6,836
-33% -$1.74M
SHCO
304
DELISTED
Soho House & Co
SHCO
$3.63M 0.06%
+292,180
New +$3.65M
SMIH
305
DELISTED
Summit Healthcare Acquisition Corp. Class A Ordinary Share
SMIH
$3.58M 0.06%
+367,600
New +$3.53M
APLS
306
DELISTED
Apellis Pharmaceuticals
APLS
$3.56M 0.06%
+108,076
New +$6.07M
TGTX icon
307
TG Therapeutics
TGTX
$7.64B
$3.56M 0.06%
106,932
+4,952
+5% +$153K
TVTX icon
308
Travere Therapeutics
TVTX
$5.84B
$3.54M 0.06%
+145,918
New +$2.68M
DYN icon
309
Dyne Therapeutics
DYN
$4.89B
$3.51M 0.06%
216,201
-6,173
-3% -$109K
ZLSWU
310
DELISTED
Zalatoris II Acquisition Corp Unit
ZLSWU
$3.48M 0.06%
+354,215
New +$3.5M
ARTA
311
DELISTED
Artisan Acquisition Corp. Class A Ordinary Shares
ARTA
$3.47M 0.06%
+350,000
New +$3.41M
YTPG
312
DELISTED
TPG Pace Beneficial II Corp.
YTPG
$3.43M 0.06%
350,000
– –
JD icon
313
JD.com
JD
$43.9B
$3.42M 0.06%
+47,310
New +$3.49M
ESM
314
DELISTED
ESM Acquisition Corporation
ESM
$3.42M 0.06%
350,000
– –
VAQC
315
DELISTED
Vector Acquisition Corporation II Class A Ordinary Shares
VAQC
$3.41M 0.06%
350,000
– –
BMEA icon
316
Biomea Fusion
BMEA
$91.1M
$3.41M 0.06%
284,977
– –
LGAC
317
DELISTED
Lazard Growth Acquisition Corp. I Ordinary Shares
LGAC
$3.41M 0.06%
350,000
– –
FRON
318
DELISTED
Frontier Acquisition Corp. Class A Ordinary Shares
FRON
$3.4M 0.06%
350,000
– –
SDST
319
Stardust Power Inc
SDST
$6.67M
$3.4M 0.06%
35,000
– –
UFS
320
DELISTED
DOMTAR CORPORATION (New)
UFS
$3.34M 0.05%
+61,204
New +$3.36M
TPTX
321
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$3.34M 0.05%
50,228
+3,228
+7% +$230K
MTEM
322
DELISTED
Molecular Templates, Inc.
MTEM
$3.33M 0.05%
33,081
-5,950
-15% -$614K
SAP icon
323
SAP
SAP
$228B
$3.32M 0.05%
+24,597
New +$3.57M
SLCR
324
DELISTED
Silver Crest Acquisition Corporation Class A Ordinary Share
SLCR
$3.29M 0.05%
334,709
– –
LGV
325
DELISTED
Longview Acquisition Corp. II
LGV
$3.21M 0.05%
325,000
– –
11 12
13
14 15

Similar funds

PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
VAI
Vanguard Advisers Inc Malvern, Pennsylvania $25.5B AUM

Woodline Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Woodline Partners held 794 positions worth $6.12B, up 14% from $5.36B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Woodline Partners deployed $908M of net new capital in Q3 2021, opening 208 new positions and adding to 110 existing holdings. Its largest new stake was Qualcomm: 599,018 shares worth $77.3M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, down from 47% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Amphenol, an estimated $98.7M trimmed.

  • Woodline Partners's largest Q3 2021 buy was Qualcomm: 599,018 shares worth $77.3M.
  • Woodline Partners added most to Teradyne in Q3 2021, an estimated $52.2M increase.
  • Woodline Partners's biggest Q3 2021 reduction was Amphenol, cutting an estimated $98.7M.
  • Woodline Partners fully exited Boston Scientific in Q3 2021, selling an estimated $44.9M.
  • Woodline Partners's ten largest holdings make up 16% of its $6.12B portfolio in Q3 2021.
  • Woodline Partners opened 208 new positions and closed 121 in Q3 2021.
  • Woodline Partners's portfolio value rose 14% quarter-over-quarter to $6.12B.

Based on Woodline Partners's 13F filing for Q3 2021, filed 15 Nov 2021.